Marchex Q3 Adj EPS $(0.01) Beats $(0.03) Estimate, Sales $12.78M Beat $12.75M Estimate
Portfolio Pulse from bharat@benzinga.com
Marchex (NASDAQ:MCHX) reported Q3 losses of $(0.01) per share, beating the analyst consensus estimate of $(0.03) by 66.67 percent. This is unchanged from the same period last year. The company also reported quarterly sales of $12.78 million, beating the analyst consensus estimate of $12.75 million by 0.22 percent, though this is a 3.17 percent decrease over sales of $13.20 million the same period last year.
November 08, 2023 | 10:23 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Marchex's Q3 results beat analyst estimates, with losses per share and sales both exceeding expectations. However, sales are down 3.17% compared to the same period last year.
While Marchex's Q3 results beat analyst estimates, which could have a positive impact on the stock, the decrease in sales compared to the same period last year could offset this positive impact, leading to a neutral short term price direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100